Immunocore Holdings plc (IMCR) Tops Q3 EPS by 24c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q3 EPS of $0.00, $0.24 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $103.69 million versus the consensus estimate of $101.94 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance